A selective delta 1 opioid receptor agonist derived from oxymorphone. Evidence for separate recognition sites for delta 1 opioid receptor agonists and antagonists
Portoghese, P.S.; Moe, S.T.; Takemori, A.E.
Journal of Medicinal Chemistry 36(17): 2572-2574
1993
ISSN/ISBN: 0022-2623
PMID: 8394935
DOI: 10.1021/jm00069a017
Accession: 045109909
PDF emailed within 0-6 h: $19.90
Related References
Noble, F.; Fournie-Zaluski, M.C.; Roques, B.P. 1996: Opposite role of delta 1- and delta 2-opioid receptors activated by endogenous or exogenous opioid agonists on the endogenous cholecystokinin system: further evidence for delta-opioid receptor heterogeneity Neuroscience 75(3): 917-926Ito, S.; Mori, T.; Sawaguchi, T. 2006: Differential effects of micro-opioid, delta-opioid and kappa-opioid receptor agonists on dopamine receptor agonist-induced climbing behavior in mice Behavioural Pharmacology 17(8): 691-701
Xu, H.; Lu, Y.F.; Partilla, J.S.; Pinto, J.; Calderon, S.N.; Matecka, D.; Rice, K.C.; Lai, J.; Porreca, F.; Ananthan, S.; Rothman, R.B. 1998: Opioid peptide receptor studies. 8. one of the mouse brain deltaNCX binding sites is similar to the cloned mouse opioid delta receptor: further evidence for heterogeneity of delta opioid receptors Peptides 19(2): 343-350
Calderon, S.N.; Rice, K.C.; Rothman, R.B.; Porreca, F.; Flippen-Anderson, J.L.; Kayakiri, H.; Xu, H.; Becketts, K.; Smith, L.E.; Bilsky, E.J.; Davis, P.; Horvath, R. 1997: Probes for narcotic receptor mediated phenomena. 23. Synthesis, opioid receptor binding, and bioassay of the highly selective delta agonist (+)-4-[(alpha R)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]- N,N-diethylbenzamide (SNC 80) and related novel nonpeptide delta opioid receptor ligands Journal of Medicinal Chemistry 40(5): 695-704
Toyoshi, T.; Ukai, M.; Kameyama, T. 1992: Combination of a delta opioid receptor agonist but not a mu opioid receptor agonist with the D1-selective dopamine receptor agonist SKF 38393 markedly potentiates different behaviors in mice European Journal of Pharmacology 213(1): 25-30
Minami, M.; Nakagawa, T.; Seki, T.; Onogi, T.; Aoki, Y.; Katao, Y.; Katsumata, S.; Satoh, M. 1996: A single residue, Lys108, of the delta-opioid receptor prevents the mu-opioid-selective ligand [D-Ala2,N-MePhe4,Gly-ol5]enkephalin from binding to the delta-opioid receptor Molecular Pharmacology 50(5): 1413-1422
Sofuoglu, M.; Portoghese, P.S.; Takemori, A.E. 1991: Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes Journal of Pharmacology and Experimental Therapeutics 257(2): 676-680
Maslov, L.N.; Lasukova, T.V.; Bespalova, Z.D.; Oldgen, P.; Rice, K.K.; Nagase, H. 2004: Delta-opioid receptor antagonists exhibit properties of partial delta-receptor agonists in isolated perfused heart Bulletin of Experimental Biology and Medicine 138(4): 376-379
Bharagava, H.N.; Zhao, G.M. 1996: Effects of competitive and noncompetitive antagonists of the N-methyl-D-aspartate receptor on the analgesic action of delta 1- and delta 2-opioid receptor agonists in mice British Journal of Pharmacology 119(8): 1586-1590
Woods, J.H.; DeCosta, B.; Jacobson, A.E.; Rice, K.C.; Medzihradsky, F.; Smith, C.B.; Comer, S.; France, C.P.; Winger, G. 1989: Delta opioid receptor selective alkaloid agonists and antagonists Nida Research Monograph 95: 300-301
Zhao, G.M.; Plotnikoff, N.P.; Bhargava, H.N. 1996: Effects of multiple intracerebroventricular injections of delta-1- or delta-2- opioid receptor agonists on brain delta opioid receptors in mice Society for Neuroscience Abstracts 22(1-3): 170
Varga, E.V.; Li, X.P.; Stropova, D.; Calderon, S.; Rice, K.; Rothman, R.; Porreca, F.; Hruby, V.; Roeske, W.R.; Yamamura, H.I. 1995: Identification of regions of the human delta opioid receptor involved in the selective binding of agonists and antagonists A chimeric receptor study Society for Neuroscience Abstracts 21(1-3): 1604
Tseng, L.F.; Collins, K.A.; Kampine, J.P. 1994: Antisense oligodeoxynucleotide to a delta-opioid receptor selectively blocks the spinal antinociception induced by delta-, but not mu- or kappa-opioid receptor agonists in the mouse European Journal of Pharmacology 258(1-2): R1-R3
Narita, M.; Narita, M.; Bosnjak, Z.J.; Kampine, J.P.; Tseng, L.F. 1995: The antisense oligo to delta-opioid receptor mRNA prevents the recovery from acute antinociceptive tolerance to delta-, but not mu- or kappa-opioid receptor agonists in the mouse Society for Neuroscience Abstracts 21(1-3): 724
Schiller, P.W.; Weltrowska, G.; Berezowska, I.; Nguyen, T.M.; Wilkes, B.C.; Lemieux, C.; Chung, N.N. 1999: The TIPP opioid peptide family: development of delta antagonists, delta agonists, and mixed mu agonist/delta antagonists Biopolymers 51(6): 411-425
Wang, H.Q.; Kampine, J.P.; Tseng, L.F. 1996: Antisense oligodeoxynucleotide to a delta-opioid receptor messenger RNA selectively blocks the antinociception induced by intracerebroventricularly administered delta-, but not mu-, epsilon- or kappa-opioid receptor agonists in the mouse Neuroscience 75(2): 445-452
Meucci, E.; Delay-Goyet, P.; Roques, B.P.; Zajac, J.M. 1989: Binding in vivo of selective mu and delta opioid receptor agonists: opioid receptor occupancy by endogenous enkephalins European Journal of Pharmacology 171(2-3): 167-178
Narita, M.; Mizoguchi, H.; Kampine, J.P.; Tseng, L.F. 1997: The effect of pretreatment with a delta-2-opioid receptor antisense oligodeoxynucleotide on the recovery from acute antinociceptive tolerance to delta-2-opioid receptor agonist in the mouse spinal cord British Journal of Pharmacology 120(4): 587-592
Tseng, L.F.; Narita, M.; Mizoguchi, H.; Kawai, K.; Mizusuna, A.; Kamei, J.; Suzuki, T.; Nagase, H. 1997: Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord Journal of Pharmacology and Experimental Therapeutics 280(2): 600-605
Schiller, P.W.; Weltrowska, G.; Nguyen, T.M.-D.; Lemieux, C.; Chung, N.N.; Lu, Y. 2003: Conversion of delta-, kappa- and mu-receptor selective opioid peptide agonists into delta-, kappa- and mu-selective antagonists Life Sciences 73(6): 691-698